Article abstract


Nature Medicine 13, 695 - 702 (2007)
Published online: 27 May 2007 | doi:10.1038/nm1587

Retinaldehyde represses adipogenesis and diet-induced obesity

Ouliana Ziouzenkova1, Gabriela Orasanu1, Molly Sharlach1, Taro E Akiyama2, Joel P Berger2, Jason Viereck3, James A Hamilton3, Guangwen Tang4, Gregory G Dolnikowski4, Silke Vogel5, Gregg Duester6 & Jorge Plutzky1


The metabolism of vitamin A and the diverse effects of its metabolites are tightly controlled by distinct retinoid-generating enzymes, retinoid-binding proteins and retinoid-activated nuclear receptors. Retinoic acid regulates differentiation and metabolism by activating the retinoic acid receptor and retinoid X receptor (RXR), indirectly influencing RXR heterodimeric partners. Retinoic acid is formed solely from retinaldehyde (Rald), which in turn is derived from vitamin A. Rald currently has no defined biologic role outside the eye. Here we show that Rald is present in rodent fat, binds retinol-binding proteins (CRBP1, RBP4), inhibits adipogenesis and suppresses peroxisome proliferator-activated receptor-gamma and RXR responses. In vivo, mice lacking the Rald-catabolizing enzyme retinaldehyde dehydrogenase 1 (Raldh1) resisted diet-induced obesity and insulin resistance and showed increased energy dissipation. In ob/ob mice, administrating Rald or a Raldh inhibitor reduced fat and increased insulin sensitivity. These results identify Rald as a distinct transcriptional regulator of the metabolic responses to a high-fat diet.

Top
  1. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
  2. Merck Research Laboratories, Rahway, New Jersey 07065, USA.
  3. Department of Physiology and Biophysics, Boston University, Boston, Massachusetts, 02118, USA.
  4. Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts 02111, USA.
  5. Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
  6. OncoDevelopmental Biology Program, Burnham Institute for Medical Research, La Jolla, California 92037, USA.

Correspondence to: Jorge Plutzky1 e-mail: jplutzky@rics.bwh.harvard.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Retinaldehyde: more than meets the eye

Nature Medicine News and Views (01 Jun 2007)

Stress, diet and abdominal obesity: Y?

Nature Medicine News and Views (01 Jul 2007)


Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

ADVERTISEMENT